The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
A Range of Research-Based Pharmacotherapies for Addiction
Abstract
Modern approaches to the treatment of addiction have been influenced by several important factors. These include advances in our understanding of the nature of addiction based on longitudinal studies, and progress in elucidating the biological underpinnings of addictive behavior. In addition, changes in the system for delivery of services have begun to shape the way that addiction is treated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McLELLAN, A. T., LUBORSKY, L., WOODY, G. E., & O??BRIEN, C. P. (1980) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-198001000-00006 · Cited by 3,188
Self-citationThe self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence
(1985) · American Journal of Psychiatry · doi:10.1176/ajp.142.11.1259 · Cited by 2,538
Drug abuse: hedonic homeostatic dysregulation
Koob, G. F., & Moal, M. L. (1997) · Science · doi:10.1126/science.278.5335.52 · Cited by 2,535
Pain and Its Treatment in Outpatients with Metastatic Cancer
Cleeland, C. S., Gonin, R., Hatfield, A. K., Edmonson, J. H., Blum, R. H., Stewart, J. A., & Pandya, K. J. (1994) · New England Journal of Medicine · doi:10.1056/nejm199403033300902 · Cited by 2,019
Naltrexone in the Treatment of Alcohol Dependence
Volpicelli, J. R. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820110040006 · Cited by 1,828
Naltrexone and Coping Skills Therapy for Alcohol Dependence: A Controlled Study
O'Malley, S. S. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820110045007 · Cited by 1,487
Kessler, R. C., Nelson, C. B., McGonagle, K. A., Edlund, M. J., Frank, R. G., & Leaf, P. J. (1996) · American Journal of Orthopsychiatry · doi:10.1037/h0080151 · Cited by 1,378
Pharmacological characterization of the cloned kappa-, delta-, and mu-opioid receptors.
Raynor, K., Kong, H., Chen, Y., Yasuda, K., Yu, L., Bell, G. I., & Reisine, T. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09932-8 · Cited by 665
Dynamics of Drug Dependence: Implications of a Conditioning Theory for Research and Treatment
Wikler, A. (1973) · Archives of General Psychiatry · doi:10.1001/archpsyc.1973.01750350005001 · Cited by 648
The Effectiveness of Methadone Maintenance Treatment
Ball, J. C., & Ross, A. (1991) · Springer eBooks · doi:10.1007/978-1-4613-9089-3 · Cited by 590
Cited by
Drug Addiction, Dysregulation of Reward, and Allostasis
Koob, G. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00195-0 · Cited by 2,953
Drug abuse: hedonic homeostatic dysregulation
Koob, G. F., & Moal, M. L. (1997) · Science · doi:10.1126/science.278.5335.52 · Cited by 2,535
Jentsch, J. D., & Taylor, J. R. (1999) · Psychopharmacology · doi:10.1007/pl00005483 · Cited by 1,545
The psychology and neurobiology of addiction: an incentive–sensitization view
Robinson, T. E., & Berridge, K. C. (2000) · Addiction · doi:10.1046/j.1360-0443.95.8s2.19.x · Cited by 1,507
Drugs of Abuse and Stress Trigger a Common Synaptic Adaptation in Dopamine Neurons
Saal, D., Dong, Y., Bonci, A., & Malenka, R. C. (2003) · Neuron · doi:10.1016/s0896-6273(03)00021-7 · Cited by 1,147
The genetics of addictions: uncovering the genes
Goldman, D., Oroszi, G., & Ducci, F. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1635 · Cited by 1,099
Neurobiology of relapse to heroin and cocaine seeking: a review
Shalev, U., Grimm, J. W., & Shaham, Y. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.1.1 · Cited by 880
Addiction and Cue-Triggered Decision Processes
Bernheim, B. D., & Rangel, A. (2004) · American Economic Review · doi:10.1257/0002828043052222 · Cited by 732
Stress-induced relapse to heroin and cocaine seeking in rats: a review
Shaham, Y., Erb, S., & Stewart, J. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(00)00024-2 · Cited by 700
The behavioral economics of substance use disorders: reinforcement pathologies and their repair
Bickel, W. K., Johnson, M. W., Koffarnus, M. N., MacKillop, J., & Murphy, J. G. (2014) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-032813-153724 · Cited by 655
Drug Wanting: Behavioral Sensitization and Relapse to Drug-Seeking Behavior
Steketee, J. D., & Kalivas, P. W. (2011) · Pharmacological Reviews · doi:10.1124/pr.109.001933 · Cited by 650
Toward a model of drug relapse: an assessment of the validity of the reinstatement procedure
Epstein, D. H., Preston, K. L., Stewart, J., & Shaham, Y. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0529-6 · Cited by 620
Amato, L., Davoli, M., A.Perucci, C., Ferri, M., Faggiano, F., & P. Mattick, R. (2005) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2005.02.007 · Cited by 567
“…medications suggest that people who are dependent on opioid will benefit from patterns of treatment similar to those provided to patients with other chronic disorders (e.g., schizophrenia, depression, diabetes), with continuing care and monitoring over time (McLellan et al., 2000; O’Brien, 1997).”
BackgroundArousal and reward: a dichotomy in orexin function
Harris, G. C., & Aston-Jones, G. (2006) · Trends in Neurosciences · doi:10.1016/j.tins.2006.08.002 · Cited by 565
Grimm, J. W., Lu, L., Hayashi, T., Hope, B. T., Su, T.-P., & Shaham, Y. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-03-00742.2003 · Cited by 550
Role for hypocretin in mediating stress-induced reinstatement of cocaine-seeking behavior
Boutrel, B., Kenny, P. J., Specio, S. E., Martin-Fardon, R., Markou, A., Koob, G. F., & de Lecea, L. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507480102 · Cited by 520
Ito, R., Dalley, J. W., Robbins, T. W., & Everitt, B. J. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-14-06247.2002 · Cited by 463
Disciplining Addictions: The Bio-politics of Methadone and Heroin in the United States
Bourgois, P. (2000) · Culture, Medicine and Psychiatry · doi:10.1023/a:1005574918294 · Cited by 457
Incubation of cocaine craving after withdrawal: a review of preclinical data
Lu, L., Grimm, J. W., Hope, B. T., & Shaham, Y. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.06.027 · Cited by 446
Central amygdala ERK signaling pathway is critical to incubation of cocaine craving
Lu, L., Hope, B. T., Dempsey, J., Liu, S. Y., Bossert, J. M., & Shaham, Y. (2005) · Nature Neuroscience · doi:10.1038/nn1383 · Cited by 443
Volkow, N. D., Wang, G.-J., Fowler, J. S., Logan, J., Gatley, S. J., Wong, C., Hitzemann, R., & Pappas, N. R. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35115-8 · Cited by 422
Synaptic mechanisms underlying persistent cocaine craving
Wolf, M. E. (2016) · Nature Reviews Neuroscience · doi:10.1038/nrn.2016.39 · Cited by 393
Science is Revolutionizing Our View of Addiction—and What to Do About It
LESHNER, A. I. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.1.1 · Cited by 368
Transition to Addiction Is Associated with a Persistent Impairment in Synaptic Plasticity
Kasanetz, F., Deroche-Gamonet, V., Berson, N., Balado, E., Lafourcade, M., Manzoni, O., & Piazza, P. V. (2010) · Science · doi:10.1126/science.1187801 · Cited by 364
Rimondini, R., Arlinde, C., Sommer, W., & Heilig, M. (2002) · The FASEB Journal · doi:10.1096/fj.01-0593com · Cited by 321
The Role of Orbitofrontal Cortex in Drug Addiction: A Review of Preclinical Studies
Schoenbaum, G., & Shaham, Y. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.06.003 · Cited by 317
Crain, S. M., & Shen, K.-F. (2000) · Pain · doi:10.1016/s0304-3959(99)00223-7 · Cited by 306
Sufficiency of Mesolimbic Dopamine Neuron Stimulation for the Progression to Addiction
Pascoli, V., Terrier, J., Hiver, A., & Lüscher, C. (2015) · Neuron · doi:10.1016/j.neuron.2015.10.017 · Cited by 304
Opioids, Reward and Addiction: An Encounter of Biology, Psychology, and Medicine
van Ree, J. M., Gerrits, M. A. F. M., & Vanderschuren, L. J. M. J. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01405-4 · Cited by 303
Shalev, U., Morales, M., Hope, B., Yap, J., & Shaham, Y. (2001) · Psychopharmacology · doi:10.1007/s002130100748 · Cited by 289
Lu, L., Dempsey, J., Liu, S. Y., Bossert, J. M., & Shaham, Y. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.5124-03.2004 · Cited by 282
Pain and Poppies: The Good, the Bad, and the Ugly of Opioid Analgesics
Trang, T., Al-Hasani, R., Salvemini, D., Salter, M. W., Gutstein, H., & Cahill, C. M. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.2711-15.2015 · Cited by 273
Neurobiology of relapse to heroin and cocaine seeking: An update and clinical implications
Bossert, J. M., Ghitza, U. E., Lu, L., Epstein, D. H., & Shaham, Y. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.09.030 · Cited by 271
Schmidt, H. D., & Pierce, R. C. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05144.x · Cited by 254
Smith, R. J., & Aston-Jones, G. (2008) · Brain Structure and Function · doi:10.1007/s00429-008-0191-3 · Cited by 206
“A major obstacle in drug addiction recovery is the susceptibility to relapse, even after extended periods of abstinence (O’Brien 1997).”
BackgroundSchwarz, J. M., Hutchinson, M. R., & Bilbo, S. D. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.3297-11.2011 · Cited by 203
Neurobiology of dysregulated motivational systems in drug addiction
Edwards, S., & Koob, G. F. (2010) · Future Neurology · doi:10.2217/fnl.10.14 · Cited by 157
“Drug withdrawal-induced neuroadaptations Relapse vulnerability is a defining feature of drug addiction and can persist for several months of abstinence from the drug [162].”
BackgroundCarroll, K. M., & Rounsaville, B. J. (2003) · Psychiatric Services · doi:10.1176/appi.ps.54.3.333 · Cited by 155
Wang, J., Fang, Q., Liu, Z., & Lu, L. (2006) · Psychopharmacology · doi:10.1007/s00213-005-0262-6 · Cited by 134
“The main problem in drug addiction treatment is the relapse to drug use after periods of abstinence (Mendelson and Mello 1996; O'Brien 1997).”
What Works in Substance Abuse Treatment Programs for Offenders?
Bahr, S. J., Masters, A. L., & Taylor, B. M. (2012) · The Prison Journal · doi:10.1177/0032885512438836 · Cited by 107
“These are termed antagonists and may reduce cravings (O’Brien, 1997).”
BackgroundJentsch, J. D., Roth, R. H., & Taylor, J. R. (2000) · Progress in Brain Research · doi:10.1016/s0079-6123(00)26028-7 · Cited by 99
Wang, X., Luo, Y.-X., He, Y.-Y., Li, F.-Q., Shi, H.-S., Xue, L.-F., Xue, Y.-X., & Lu, L. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.1264-10.2010 · Cited by 88
Medication screening for smoking cessation: A proposal for new methodologies
Perkins, K. A., Stitzer, M., & Lerman, C. (2006) · Psychopharmacology · doi:10.1007/s00213-005-0105-5 · Cited by 91
Highfield, D. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00227-5 · Cited by 81
Morphine‐associated environmental cues elicit conditioned gene expression
Schroeder, B. E., Holahan, M. R., Landry, C. F., & Kelley, A. E. (2000) · Synapse · doi:10.1002/1098-2396(200008)37:2<146::aid-syn8>3.0.co;2-# · Cited by 65
Parvaz, M. A., Maloney, T., Moeller, S. J., Woicik, P. A., Alia-Klein, N., Telang, F., Wang, G.-J., Squires, N. K., Volkow, N. D., & Goldstein, R. Z. (2012) · Psychiatry Research: Neuroimaging · doi:10.1016/j.pscychresns.2012.01.001 · Cited by 49
Effect of rapamycin on cue-induced drug craving in abstinent heroin addicts
Shi, J., Jun, W., Zhao, L.-Y., Xue, Y.-X., Zhang, X.-Y., Kosten, T. R., & Lu, L. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.05.011 · Cited by 31
Wang, L., Shen, M., Jiang, C., Ma, L., & Wang, F. (2016) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw060 · Cited by 29
Zhu, C., Li, H., Kong, X., Wang, Y., Sun, T., & Wang, F. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.819470 · Cited by 26
“As a result, once the drug use is discontinued, individuals experience a range of serious withdrawal symptoms, culminating in a craving-induced intractable relapse, which is considered a great challenge in clinical treatment (Hunt et al., 1971; O’Brien, 1997).”
Background
Metadata
- Authors
- O'Brien, C. P.
- Venue
- Science
- Published
- 1997-10-03
- Volume
- 278
- Issue
- 5335
- Pages
- 66-70
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1977247384
- Cited by
- 385
- References
- 39
- FWCI
- 12.01
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.